Search hospitals > Illinois > Springfield
Memorial Medical Center
Claim this profileSpringfield, Illinois 62702
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Recurrence
435 reported clinical trials
4 medical researchers
Summary
Memorial Medical Center is a medical facility located in Springfield, Illinois. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Recurrence and other specialties. Memorial Medical Center is involved with conducting 435 clinical trials across 570 conditions. There are 4 research doctors associated with this hospital, such as Bryan A. Faller, James L. Wade, Stephen Hazelrigg, MD, and Tony DeMartini, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Bryan A. FallerCrossroads Cancer Center1 year of reported clinical research
Expert in Cancer
Expert in Breast Cancer
220 reported clinical trials
287 drugs studied
James L. WadeDecatur Memorial Hospital3 years of reported clinical research
Studies Recurrence
Studies Breast Cancer
11 reported clinical trials
20 drugs studied
Stephen Hazelrigg, MDMemorial Medical Center6 years of reported clinical research
Studies Heart Failure
Studies Left Ventricular Dysfunction
1 reported clinical trial
1 drug studied
Tony DeMartini, MDMemorial Medical Center3 years of reported clinical research
Studies Myocardial Ischemia
Studies Coronary Artery Disease
1 reported clinical trial
1 drug studied
Clinical Trials running at Memorial Medical Center
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Prostate Cancer
Cancer
Gastric Cancer
Gastroesophageal Junction Adenocarcinoma
Squamous Cell Carcinoma
Esophageal Cancer
Renal Cell Carcinoma
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Memorial Medical Center?
Memorial Medical Center is a medical facility located in Springfield, Illinois. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Recurrence and other specialties. Memorial Medical Center is involved with conducting 435 clinical trials across 570 conditions. There are 4 research doctors associated with this hospital, such as Bryan A. Faller, James L. Wade, Stephen Hazelrigg, MD, and Tony DeMartini, MD.
Where is Memorial Medical Center located?
**Memorial Medical Center**
- **Address:** 701 N. First St., Springfield, IL 62781
- **Amenities:** Elevators, food services, free parking, patient waiting rooms, wheelchair accessibility.
Who should I call to ask about financial aid or insurance network?
**Memorial Medical Center Contact Information**
**Financial Assistance:**
- Patient Financial Services Department: 954-276-5501
- Eligibility Department: 954-276-5760
- Visit Admitting/registration areas in the main lobby of any acute care facility
- Eligibility Office Hours: Monday-Friday, 8 am to 4:30 pm
**Insurance:**
- For coverage-related questions, contact your insurance provider directly.
**Additional Assistance:**
- Customer Service Department: 989-720-2000
What insurance does Memorial Medical Center accept?
Memorial Medical Center accepts a variety of insurance plans such as Blue Cross Blue Shield, Cigna, Humana, Medicare, NM Medicaid, Presbyterian, TriCare, Western Sky, and United Health Care. MemorialCare Medical Group and Urgent Care accept major HMO, PPO, EPO health plans, Medicare, private indemnity, and supplemental insurance plans. Memorial Health and Memorial Healthcare System also support a broad spectrum of insurance options, including Commercial, ACA/Exchange, Medicare, Medicare Advantage, Medicaid, and provide a self-insured plan for businesses.
What awards or recognition has Memorial Medical Center received?
Memorial Medical Center, located in Springfield, Illinois, has been nationally recognized for its excellence in stroke care, earning the prestigious American Hospital Association's top national award for quality and safety. It holds accreditation from The Joint Commission and boasts Magnet recognition for nursing excellence. The hospital has a rich history of healthcare innovation since its founding in 1897.